Point72 Asset Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Point72 Asset Management’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.42M	Sell	1,389,403 -909,098	-40%	-$3.04M	﹤0.01%	1951
2025 Q4	$9.15M	Buy	2,298,501 +2,221,153	+2,872%	+$9.83M	0.01%	1417
2025 Q3	$292K	Buy	+77,348	New	+$263K	﹤0.01%	2075
2022 Q1	–	Sell	-16,900	Closed	-$801K	–	1271
2021 Q4	$801K	Buy	+16,900	New	+$1.01M	﹤0.01%	938

Other funds holding NBP

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

ACM

AIHC Capital Management Central $120M AUM

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return

Point72 Asset Management's NBP Position: Q1 2026 in Review

Point72 Asset Management reduced its NovaBridge Biosciences American Depositary Shares (NBP) stake by 40% in Q1 2026, selling an estimated $3.04M and leaving 1,389,403 shares worth $3.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1951.

Point72 Asset Management first reported a position in NBP in Q4 2021 and has held it in 4 quarters since. The position peaked at $9.15M in Q4 2025. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

Point72 Asset Management held 1,389,403 shares of NovaBridge Biosciences American Depositary Shares worth $3.42M as of Q1 2026.
Point72 Asset Management sold 909,098 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $3.04M.
NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #1951 holding.
Point72 Asset Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2021 and has held it in 4 quarters since.
Point72 Asset Management's NovaBridge Biosciences American Depositary Shares position peaked at $9.15M in Q4 2025.
48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.